81 related articles for article (PubMed ID: 17317052)
1. Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant.
Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
Int J Pharm; 2007 Jun; 338(1-2):87-93. PubMed ID: 17317052
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
3. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant.
Takatsuka S; Morita T; Koguchi A; Horikiri Y; Yamahara H; Yoshino H
Int J Pharm; 2006 Jun; 316(1-2):124-30. PubMed ID: 16600541
[TBL] [Abstract][Full Text] [Related]
4. Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.
Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
Int J Pharm; 2008 Feb; 349(1-2):94-100. PubMed ID: 17869034
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Jan; 110(2):347-352. PubMed ID: 16274829
[TBL] [Abstract][Full Text] [Related]
6. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Oct; 115(2):183-8. PubMed ID: 16989920
[TBL] [Abstract][Full Text] [Related]
7. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
8. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
9. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
10. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
[TBL] [Abstract][Full Text] [Related]
11. Absorption of water-soluble compounds with different molecular weights and.
Yamamoto A; Iseki T; Ochi-Sugiyama M; Okada N; Fujita T; Muranishi S
J Control Release; 2001 Oct; 76(3):363-74. PubMed ID: 11578749
[TBL] [Abstract][Full Text] [Related]
12. Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats.
He L; Gao Y; Lin Y; Katsumi H; Fujita T; Yamamoto A
J Control Release; 2007 Sep; 122(1):94-101. PubMed ID: 17651854
[TBL] [Abstract][Full Text] [Related]
13. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
14. Influence of ferulic acid on nicotine-induced lipid peroxidation, DNA damage and inflammation in experimental rats as compared to N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Devaraj H; Menon VP
Toxicology; 2008 Jan; 243(3):317-29. PubMed ID: 18068289
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
Petronilho F; Constantino L; de Souza B; Reinke A; Martins MR; Fraga CM; Ritter C; Dal-Pizzol F
Nephrol Dial Transplant; 2009 Jul; 24(7):2077-82. PubMed ID: 19204016
[TBL] [Abstract][Full Text] [Related]
16. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine.
Sakuma S; Sudo R; Suzuki N; Kikuchi H; Akashi M; Ishida Y; Hayashi M
J Control Release; 2002 Jun; 81(3):281-90. PubMed ID: 12044567
[TBL] [Abstract][Full Text] [Related]
17. Improving the cadmium-induced centriacinar emphysema model in rats by concomitant anti-oxidant treatment.
Heili Frades S; Del Puerto-Nevado L; Pérez-Rial S; Martin-Mosquero C; Ortega ; Martinez-Galán L; Rubio ML; Rodriguez Nieto MJ; González-Mangado N; Peces-Barba Romero G
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1337-42. PubMed ID: 18759863
[TBL] [Abstract][Full Text] [Related]
18. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
Lee VH; Yamamoto A; Kompella UB
Crit Rev Ther Drug Carrier Syst; 1991; 8(2):91-192. PubMed ID: 1934087
[No Abstract] [Full Text] [Related]
19. Improved paracellular uptake by the combination of different types of permeation enhancers.
Guggi D; Bernkop-Schnürch A
Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
[TBL] [Abstract][Full Text] [Related]
20. Effects of a sperminated gelatin on the nasal absorption of insulin.
Seki T; Kanbayashi H; Chono S; Tabata Y; Morimoto K
Int J Pharm; 2007 Jun; 338(1-2):213-8. PubMed ID: 17346909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
